These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36118044)

  • 1. Evaluation of environmental Mucorales contamination in and around the residence of COVID-19-associated mucormycosis patients.
    Ghosh AK; Singh R; Reddy S; Singh S; Rudramurthy SM; Kaur H; Choudhary H; Chakrabarti A
    Front Cell Infect Microbiol; 2022; 12():953750. PubMed ID: 36118044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre study.
    Biswal M; Gupta P; Kanaujia R; Kaur K; Kaur H; Vyas A; Hallur V; Behera B; Padaki P; Savio J; Nagaraj S; Chunchanur SK; Shwetha JV; Ambica R; Nagdeo N; Khuraijam R; Priyolakshmi N; Patel K; Thamke D; Dash L; Jadhav D; Bharmal R; Bhattacharya S; Rudramurthy SM; Chakrabarti A
    J Hosp Infect; 2022 Apr; 122():173-179. PubMed ID: 35124141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aero mycological analysis of Mucormycetes in indoor and outdoor environments of northern India.
    Prakash H; Singh S; Rudramurthy SM; Singh P; Mehta N; Shaw D; Ghosh AK
    Med Mycol; 2020 Jan; 58(1):118-123. PubMed ID: 30980083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diversity of clinical and environmental Mucorales isolates obtained from an investigation of mucormycosis cases among solid organ transplant recipients.
    Nguyen MH; Kaul D; Muto C; Cheng SJ; Richter RA; Bruno VM; Liu G; Beyhan S; Sundermann AJ; Mounaud S; Pasculle AW; Nierman WC; Driscoll E; Cumbie R; Clancy CJ; Dupont CL
    Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33245689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study.
    Muthu V; Kumar M; Paul RA; Zohmangaihi D; Choudhary H; Rudramurthy SM; Panda NK; Pannu AK; Sharma N; Sharma S; Chakrabarti A; Agarwal R
    Mycoses; 2021 Oct; 64(10):1291-1297. PubMed ID: 34420245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
    Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF
    Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could cattle dung burning have contributed to the epidemic of COVID-19-associated mucormycosis in India? Results of an experimental aero-mycological study.
    Kathirvel S; Muthu V; Rudramurthy SM; Kaur H; Chakrabarti A; Agarwal R
    Mycoses; 2022 Nov; 65(11):1024-1029. PubMed ID: 35726395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors.
    Chowdhary A; Gupta N; Wurster S; Kumar R; Mohabir JT; Tatavarthy S; Mittal V; Rani P; Barman P; Sachdeva N; Singh A; Sharma B; Jiang Y; Cuomo CA; Kontoyiannis DP
    Mycoses; 2023 Jun; 66(6):515-526. PubMed ID: 36790120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mucorales from clinical specimens: a 4-year experience in a single institution.
    Yang M; Lee JH; Kim YK; Ki CS; Huh HJ; Lee NY
    Ann Lab Med; 2016 Jan; 36(1):60-3. PubMed ID: 26522761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The environmental source of emerging Apophysomyces variabilis infection in India.
    Prakash H; Ghosh AK; Rudramurthy SM; Paul RA; Gupta S; Negi V; Chakrabarti A
    Med Mycol; 2016 Aug; 54(6):567-75. PubMed ID: 27118802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales.
    Kaur H; Kanaujia R; Nayak G; Ramavat AS; Patro S; Ghosh A; Chakrabarti A; Rudramurthy SM
    Indian J Med Microbiol; 2024; 50():100656. PubMed ID: 38925278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.
    Baldin C; Soliman SSM; Jeon HH; Alkhazraji S; Gebremariam T; Gu Y; Bruno VM; Cornely OA; Leather HL; Sugrue MW; Wingard JR; Stevens DA; Edwards JE; Ibrahim AS
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30068535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid screening for human-pathogenic Mucorales using rolling circle amplification.
    Dolatabadi S; Najafzadeh MJ; de Hoog GS
    Mycoses; 2014 Dec; 57 Suppl 3():67-72. PubMed ID: 25187214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
    Espinel-Ingroff A; Chakrabarti A; Chowdhary A; Cordoba S; Dannaoui E; Dufresne P; Fothergill A; Ghannoum M; Gonzalez GM; Guarro J; Kidd S; Lass-Flörl C; Meis JF; Pelaez T; Tortorano AM; Turnidge J
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1745-50. PubMed ID: 25583714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and species distribution of pathogenic Mucorales in unselected soil samples from France.
    Mousavi B; Costa JM; Arné P; Guillot J; Chermette R; Botterel F; Dannaoui E
    Med Mycol; 2018 Apr; 56(3):315-321. PubMed ID: 28992337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome analysis of
    Michael JS; Venkatesan M; Ninan MM; Solaimalai D; Sumanth LJ; Varghese L; Kurien R; Varghese RP; C GPD
    Front Cell Infect Microbiol; 2023; 13():1251456. PubMed ID: 38029246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.
    Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A
    Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress response in medically important Mucorales.
    Singh P; Paul S; Shivaprakash MR; Chakrabarti A; Ghosh AK
    Mycoses; 2016 Oct; 59(10):628-35. PubMed ID: 27292160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism.
    Petraitis V; Petraitiene R; Antachopoulos C; Hughes JE; Cotton MP; Kasai M; Harrington S; Gamaletsou MN; Bacher JD; Kontoyiannis DP; Roilides E; Walsh TJ
    Med Mycol; 2013 Jan; 51(1):72-82. PubMed ID: 22686246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.